series-b
Stage
1
Investors
About
Viridian Therapeutics develops antibody-based therapies targeting rare autoimmune diseases, with programs focused on Thyroid Eye Disease and FcRn pathways.
Explore Viridian Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.